Kinetics and metabolite profile of insulin glargine (Lantus®)

被引：0
|
作者：
Kuerzel, GU [1 ]
Sandow, J [1 ]
Seipke, G [1 ]
Lang, AM [1 ]
Mass, J [1 ]
Skrzipczyk, HJ [1 ]
机构：
[1] Aventis Pharma, Frankfurt, Germany
来源：
DIABETOLOGIA | 2001年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
798
引用
收藏
页码：A208 / A208
页数：1
相关论文
共 50 条
  • [1] Insulin glargine (Lantus®)
    Owens, DR
    Griffiths, S
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2002, 56 (06) : 460 - 466
  • [2] Insulin Glargine (Lantus) and Cancer Risk
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2009, 51 (1319): : 67 - 68
  • [3] No evidence for accumulation of insulin glargine (LANTUS)
    Biermann, E
    DIABETIC MEDICINE, 2003, 20 (04) : 333 - 334
  • [4] Semglee - Insulin Glargine Interchangeable with Lantus
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2021, 63 (1634): : 159 - 160
  • [5] No evidence for accumulation of insulin glargine (LANTUS) - Reply
    Heise, T
    DIABETIC MEDICINE, 2003, 20 (04) : 334 - 335
  • [6] Insulin glargine (Lantus), a new long-acting insulin
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2001, 43 (1110): : 65 - 66
  • [7] Rezvoglar - Another Insulin Glargine Product Interchangeable with Lantus
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2023, 65 (1673): : 56 - 56
  • [8] Evaluation of the carcinogenic potential of insulin glargine (LANTUS) in rats and mice
    Stammberger, I
    Bube, A
    Durchfeld-Meyer, B
    Donaubauer, H
    Troschau, G
    INTERNATIONAL JOURNAL OF TOXICOLOGY, 2002, 21 (03) : 171 - 179
  • [9] AT.LANTUS trial investigating treatment algorithms for insulin glargine (LANTUS®).: Results of the type 2 study
    Davies, M
    Storms, F
    Shutler, S
    Bianchi-Biscay, M
    Gomis, R
    DIABETES, 2004, 53 : A473 - A473
  • [10] Real-World Evaluation of Dosing in Patients Converted From Insulin Glargine (Lantus) to Insulin Glargine (Basaglar)
    Pitlick, Jamie M.
    Bryant, Ginelle A.
    Daly, Michael W.
    Koenigsfeld, Carrie F.
    Lehman, Nicholas
    Brueggen, Kaitlin
    McCormick, Alex
    Wellington, Katlynn
    ANNALS OF PHARMACOTHERAPY, 2020, 54 (09) : 846 - 851
12345